Predictors of angiographic restenosis in patients with coronary artery disease who have undergone percutaneous coronary intervention with drug eluting stents


  • S. Praveen Department of Cardiology, Government Medical College, Thiruvananthapuram, Kerala, India
  • Baiju R. Department of Cardiology, Government Medical College, Thiruvananthapuram, Kerala, India
  • V. V. Radhakrishnan Department of Cardiology, Government Medical College, Thiruvananthapuram, Kerala, India
  • Sarosh Kumar K. K. Department of Medicine, Academy of Medical Sciences, Pariyaram, Kannur, Kerala, India



Drug eluting stents, In-stent restenosis, PTCA


Background: Percutaneous transluminal coronary angioplasty (PTCA) is now widely accepted as a nonsurgical revascularization procedure for selected patients with CAD. In-stent restenosis (ISR) is a frequent complication after PCI which limits its long-term efficacy. Identification of those clinical and angiographic characteristics that may predict the risk of restenosis is extremely important to eliminate restenosis. In this context we conducted this study to assess the profile of patients with drug eluting stents - ISR with an emphasis on demographic characteristics, risk factors, mode of presentation and coronary angiographic characterization.

Methods: This study was a Case control study based on the catheterization registry of all patients who have undergone PCI with DES during the period from October 2012 to April 2015. All patients who have undergone PCI with DES and repeat coronary angiogram for evaluation of symptoms and detected to have ISR during same period were taken as case and age matched patients who had previously undergone PCI with DES and repeat coronary angiogram for evaluation of symptoms between 1/10/2012 to 30/4/2015 and detected to have fully patent stents were taken as control.

Results: A total of 26 patients were detected to have ISR during the study period as per the study protocol with equal number of age matched controls. The most common presentation of ISR was as chronic stable angina (70%). Binary logistic regression analysis of 6 factors namely diabetes, hypertension, lesion type, stent diameter, stent length and stent overlap found significant in univariate analysis, showed only the lesion type to be statistically significant with p value of 0.023.

Conclusions: Patients who have undergone PCI with DES particularly for complex lesions, diabetics with longer stents, lesser diameter stents and overlapping stents need to be meticulously followed up to rule out the possibility of restenosis, as in a small number of patients the presentation could be ACS with comparatively bad prognosis.


Leimgruber PP, Roubin GS, Hollman J. Restenosis after successful coronaangioplasty in patients with single vessel disease. Circulation. 1986;73:710-7.

Kaltenbach M, Kober G, Scherer D, Vallbracht C. Recurrence rate after successful coronary angioplasty. Eur Heart J. 1985;6:276-81.

Levine S, Ewels CJ, Rosing DR, Kent KM. Coronary angioplasty: clinical and angiographic follow-up. Am J Cardiol. 1985;55:673-6.

Holmes DR, Vlietstra RE, Smith HC. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984;53:77C-8IC.

Mabin TA, Holmes DR, Smith HC, et al. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation. 1985;71:754-60.

Bertrand ME, LeBranche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. J Am Coll Cardiol. 1986;8:504-8.

Whitworth HB, Roubin GS, Hollman J. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1986;8:1271-6.

Cutlip DE, Windecker S, Mehran R. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.

Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.

Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.

Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.

Lemos PA, Hoye A, Goedhart D. Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam CardiologyHospital (RESEARCH) Study. Circulation. 2004;109;1366-70.

Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pacheet J, et al. Drug-Eluting Stents and Predictors of Restenosis Circulation. 2006;113:2293-300.

Mohan S, Dhall A. A comparative study of restenosis rates in bare metal and drug-eluting stents. Int J Angiol. 2010;19(2):e66e72.

Moses JW, Leon MB, Popma JJ, et al. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery NEJM. 2003;349:14.

Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, et al. Incidence and Predictors of Restenosis After Coronary Stenting in 10,004 Patients with Surveillance Angiography. Heart. 2014;100(2):153-9.

De Labriolle A, Bonello L, Lemesle G. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents Arch Cardiovasc Dis. 2009;102:209-17.

Latib A, Mussardo M, Ielasi A. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:155-164.

Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invas Cardiol. 2008;20:401-3.

Sharma SK, Duvvuri S, Dangas G. Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases. J Am Coll Cardiol. 1998;32:1358-65.

Mehran R, Dangas G, Abizaid AS. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulat. 1999;100:1872-8.

Rathore S, Kinoshita Y, Terashima M. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. Euro Intervent. 2010;5:841-6.




How to Cite

Praveen, S., R., B., Radhakrishnan, V. V., & K. K., S. K. (2018). Predictors of angiographic restenosis in patients with coronary artery disease who have undergone percutaneous coronary intervention with drug eluting stents. International Journal of Research in Medical Sciences, 6(2), 448–454.



Original Research Articles